Longo, R. et al. 2022. Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study. Acta Oncologica. 61, 11 (Nov. 2022), 1394–1399. DOI:https://doi.org/10.1080/0284186X.2022.2132115.